156 related articles for article (PubMed ID: 30698090)
1. Specialty Drug Price Trends in the Federal 340B Drug Discount Program.
Lee CH; Chang J; McCombs J
J Manag Care Spec Pharm; 2019 Feb; 25(2):178-187. PubMed ID: 30698090
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Specialty Drug Price Trends Using Data from Retrospective Pharmacy Sales Transactions.
Penington R; Stubbings JA
J Manag Care Spec Pharm; 2016 Sep; 22(9):1010-7. PubMed ID: 27574742
[TBL] [Abstract][Full Text] [Related]
3. Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.
Dickson S; Reynolds I
JAMA Netw Open; 2019 Jul; 2(7):e196541. PubMed ID: 31276176
[TBL] [Abstract][Full Text] [Related]
4. Association Between the Percentage of US Drug Sales Subject to Inflation Penalties and the Extent of Drug Price Increases.
Dickson S
JAMA Netw Open; 2020 Sep; 3(9):e2016388. PubMed ID: 32915237
[TBL] [Abstract][Full Text] [Related]
5. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
Wilson L; Turkistani FA; Huang W; Tran DM; Lin TK
PLoS One; 2018; 13(5):e0197449. PubMed ID: 29799850
[TBL] [Abstract][Full Text] [Related]
6. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
Conti RM; Nikpay SS; Buntin MB
JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
[TBL] [Abstract][Full Text] [Related]
7. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
Ruley M; Belcher M; Sayre H; Coustasse A
Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
[TBL] [Abstract][Full Text] [Related]
8. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract][Full Text] [Related]
9. Using 340B drug discounts to provide a financially sustainable medication discharge service.
Wu T; Williams C; Vranek K; Mattingly TJ
Res Social Adm Pharm; 2019 Jan; 15(1):114-116. PubMed ID: 29606609
[TBL] [Abstract][Full Text] [Related]
10. Impact of the 340B Pharmacy Program on Services and Supports for Persons Served by Hemophilia Treatment Centers in the United States.
Malouin RA; Mckernan L; Forsberg A; Cheng D; Drake J; McLaughlin K; Trujillo M
Matern Child Health J; 2018 Sep; 22(9):1240-1246. PubMed ID: 29948762
[TBL] [Abstract][Full Text] [Related]
11. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.
Clark BL; Hou J; Chou CH; Huang ES; Conti R
Health Aff (Millwood); 2014 Nov; 33(11):2012-7. PubMed ID: 25367997
[TBL] [Abstract][Full Text] [Related]
12. 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule.
Health Resources and Services Administration, Department of Health and Human Services (HHS)
Fed Regist; 2017 Jan; 82(3):1210-30. PubMed ID: 28071875
[TBL] [Abstract][Full Text] [Related]
13. Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
Mattingly TJ; Levy JF; Slejko JF; Onwudiwe NC; Perfetto EM
Pharmacoeconomics; 2018 Sep; 36(9):1093-1099. PubMed ID: 29752675
[TBL] [Abstract][Full Text] [Related]
14. Examining the Benefits of the 340b Drug Discount Program.
Gerlach J; McSweeney S; Swearingen A; Coustasse A
Health Care Manag (Frederick); 2018; 37(3):225-231. PubMed ID: 29901471
[TBL] [Abstract][Full Text] [Related]
15. Challenges for Managed Care from 340B Contract Pharmacies.
Fein AJ
J Manag Care Spec Pharm; 2016 Mar; 22(3):197-203. PubMed ID: 27003548
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount Program.
Zeta LM
Food Drug Law J; 2015; 70(4):481-99, i. PubMed ID: 26827389
[TBL] [Abstract][Full Text] [Related]
17. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a $4 generic drug program in a 340B pharmacy.
Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
[TBL] [Abstract][Full Text] [Related]
19. Association of 340B contract pharmacy growth with county-level characteristics.
Nikpay S; Gracia G; Geressu H; Conti R
Am J Manag Care; 2022 Mar; 28(3):133-136. PubMed ID: 35404549
[TBL] [Abstract][Full Text] [Related]
20. Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.
Robinson JC; Whaley C; Dhruva SS
N Engl J Med; 2024 Jan; 390(4):338-345. PubMed ID: 38265645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
